Hirofumi Shoda (H Shoda)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 15

Top Topics

Interstitial Lung Disease

Top Venues

Rheumatology international

Scandinavian journal of rheumatology

Science immunology

The Journal of rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

R Yoshihara, Haruka Tsuchiya, Hirofumi Shoda, Keishi Fujio
Relationship between earlier introduction of tocilizumab and glucocorticoid-sparing effects on the acute phase of adult-onset Still's disease. Scandinavian journal of rheumatology (2024)
Manaka Goto, Hideyuki Takahashi, Ryochi Yoshida, Takahiro Itamiya, Masahiro Nakano, Yasuo Nagafuchi, Hiroaki Harada, Toshiaki Shimizu, Meiko Maeda, Akatsuki Kubota, Tatsushi Toda, Hiroaki Hatano, Yusuke Sugimori, Kimito Kawahata, Kazuhiko Yamamoto, Hirofumi Shoda, Kazuyoshi Ishigaki, Mineto Ota, Tomohisa Okamura, Keishi Fujio
Age-associated CD4 + T cells with B cell-promoting functions are regulated by ZEB2 in autoimmunity. Science immunology 9 (93) (2024)
Hiroaki Harada, Hirofumi Shoda, Haruka Tsuchiya, Makoto Misaki, Takayuki Sawada, Keishi Fujio
Baricitinib for anti-melanoma differentiation-associated protein 5 antibody-positive dermatomyositis-associated interstitial lung disease: a case series and literature review on Janus kinase inhibitors for the disease. Rheumatology international 44 (5) (2024)
Hiroaki Harada, Hirofumi Shoda, Haruka Tsuchiya, Makoto Misaki, Takayuki Sawada, Keishi Fujio
Baricitinib for anti-melanoma differentiation-associated protein 5 antibody-positive dermatomyositis-associated interstitial lung disease: a case series and literature review on Janus kinase inhibitors for the disease. Rheumatology international 44 (5) (2024)
R Yoshihara, Haruka Tsuchiya, Hirofumi Shoda, Keishi Fujio
Relationship between earlier introduction of tocilizumab and glucocorticoid-sparing effects on the acute phase of adult-onset Still's disease. Scandinavian journal of rheumatology 53 (4) (2024)
Manaka Goto, Hideyuki Takahashi, Ryochi Yoshida, Takahiro Itamiya, Masahiro Nakano, Yasuo Nagafuchi, Hiroaki Harada, Toshiaki Shimizu, Meiko Maeda, Akatsuki Kubota, Tatsushi Toda, Hiroaki Hatano, Yusuke Sugimori, Kimito Kawahata, Kazuhiko Yamamoto, Hirofumi Shoda, Kazuyoshi Ishigaki, Mineto Ota, Tomohisa Okamura, Keishi Fujio
Age-associated CD4 + T cells with B cell-promoting functions are regulated by ZEB2 in autoimmunity. Science immunology 9 (93) (2024)
Yusuke Yamamoto, Hirofumi Shoda, Tetsuji Sawada
Lincoln Sign in Synovitis, Acne, Pustulosis, Hyperostosis, and Osteomyelitis Syndrome. The Journal of rheumatology (2024)
Manaka Goto, Hideyuki Takahashi, Ryochi Yoshida, Takahiro Itamiya, Masahiro Nakano, Yasuo Nagafuchi, Hiroaki Harada, Toshiaki Shimizu, Meiko Maeda, Akatsuki Kubota, Tatsushi Toda, Hiroaki Hatano, Yusuke Sugimori, Kimito Kawahata, Kazuhiko Yamamoto, Hirofumi Shoda, Kazuyoshi Ishigaki, Mineto Ota, Tomohisa Okamura, Keishi Fujio
Age-associated CD4 + T cells with B cell-promoting functions are regulated by ZEB2 in autoimmunity. Science immunology (2024)
Hiroaki Harada, Hirofumi Shoda, Haruka Tsuchiya, Makoto Misaki, Takayuki Sawada, Keishi Fujio
Baricitinib for anti-melanoma differentiation-associated protein 5 antibody-positive dermatomyositis-associated interstitial lung disease: a case series and literature review on Janus kinase inhibitors for the disease. Rheumatology international 44 (5) (2024)
Hiroaki Harada, Hirofumi Shoda, Haruka Tsuchiya, Makoto Misaki, Takayuki Sawada, Keishi Fujio
Baricitinib for anti-melanoma differentiation-associated protein 5 antibody-positive dermatomyositis-associated interstitial lung disease: a case series and literature review on Janus kinase inhibitors for the disease. Rheumatology international (2024)
Hirofumi Shoda, Bunki Natsumoto, Keishi Fujio
Investigation of immune-related diseases using patient-derived induced pluripotent stem cells. Inflammation and regeneration 43 (1) (2023)
Toshihiko Komai, T Sawada, Haruka Tsuchiya, Hiroaki Harada, Hirofumi Shoda, Keishi Fujio
Resolution of exacerbated rheumatoid arthritis-associated interstitial lung disease under baricitinib treatment. Scandinavian journal of rheumatology (2023)
Shinji Izuka, Toshihiko Komai, Hirofumi Shoda, Keishi Fujio
Long-term risks of malignancy in myositis-specific antibody-positive idiopathic inflammatory myopathy. Rheumatology international (2022)
Takahiro Itamiya, Toshihiko Komai, Hiroko Kanda, Yasuo Nagafuchi, Hyangri Chang, Shota Shibata, Hiroyuki Ishiura, Hirofumi Shoda, Tatsushi Toda, Keishi Fujio
Efficacy of canakinumab on AA amyloidosis in late-onset NLRP3-associated autoinflammatory disease with an I574F somatic mosaic mutation. Clinical rheumatology 41 (7) (2022)
Norio Hanata, Hirofumi Shoda, Yumi Tsuchida, Yasuo Nagafuchi, Keishi Fujio
Comment on: Neutrophil extracellular traps in giant cell arteritis biopsies: presentation, localization and co-expression with inflammatory cytokines. Rheumatology (Oxford, England) (2021)